BioCardia Partners with CART-Tech for Heart3D™ Imaging

BioCardia ( (BCDA) ) has provided an update.

On August 13, 2025, BioCardia, Inc. and CART-Tech, B.V. announced an exclusive development and commercialization agreement for Heart3D™ Fusion Imaging, aimed at enhancing cardiac biotherapeutic delivery and biopsy procedures. The system, which fuses two-dimensional x-ray images with three-dimensional anatomical heart models, is initially intended for research use and may later be approved for standard clinical practice. This partnership leverages both companies’ expertise and intellectual property, with BioCardia securing exclusive distribution rights for biotherapeutic delivery worldwide and cardiac biopsy in the U.S. The collaboration is expected to improve procedural planning and real-time image precision, potentially generating significant revenue if adopted as a standard of care.

The most recent analyst rating on (BCDA) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on BioCardia stock, see the BCDA Stock Forecast page.

Spark’s Take on BCDA Stock

According to Spark, TipRanks’ AI Analyst, BCDA is a Neutral.

BioCardia’s overall stock score is primarily constrained by its challenging financial performance and unattractive valuation. The stock’s technical indicators suggest bearish momentum. However, recent clinical advancements and corporate events provide a potential for future growth, which slightly offsets the negative aspects.

To see Spark’s full report on BCDA stock, click here.

More about BioCardia

BioCardia, Inc., headquartered in Sunnyvale, California, is a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease. Its biotherapeutic platforms include CardiAMP® autologous and CardiALLO™ allogeneic cell therapies, with three clinical stage product candidates in development. These therapies are supported by its Helix biotherapeutic delivery and Morph® vascular navigation product platforms.

Average Trading Volume: 308,432

Technical Sentiment Signal: Sell

Current Market Cap: $10.09M

See more data about BCDA stock on TipRanks’ Stock Analysis page.